Abstract
Benign prostatic hyperplasia (BPH) is one of the most common causes of lower urinary tract symptoms (LUTS) in aging men. Over the age of 60, more than a half of men have BPH and/or bothersome LUTS. Contemporary guidelines advocate surgery as the standard of care for symptomatic BPH after failure of medical therapy, where the choice of the appropriate surgical procedure depends on the prostate size. Transurethral resection of the prostate (TURP) and simple open prostatectomy (OP) have been considered for decades the reference-standard techniques for men with prostate smaller and larger than 80 ml, respectively. However, both procedures are potentially associated with considerable perioperative morbidity which prompted the introduction of a variety of minimally invasive surgical techniques with comparable long-term outcomes compared to TURP and OP. Nevertheless, the management of prostates larger than 100 ml remains a clinical challenge. Transurethral anatomical enucleation of the prostate utilizing different laser energy represents an excellent alternative concept in transurethral BPH surgery. These procedures gained popularity and demonstrated similar outcomes to OP with the advantages of favorable morbidity profiles and shorter catheter time and hospital stay. Despite the fact that OP remains a viable treatment option for patients with bothersome LUTS secondary to very large prostates, this procedure has been to a large extent replaced by these emerging enucleation techniques. Given the advent of surgical alternatives, the current review presents an evidence-based comparison of the efficacy and safety profile of the currently available transurethral laser techniques with the standard OP for the management of BPH due to adenomas larger than 100 ml.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
McConnell JD. The pathophysiology of benign prostatic hyperplasia. J Androl. 1991;12:356–63.
Gu FL, **a TL, Kong XT. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China. Urology. 1994;44:688–91.
Girman CJ, Jacobsen SJ, Tsukamoto T, Richard F, Garraway WM, Sagnier PP, et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology. 1998;51:428–36.
Welch G, Weinger K, Barry MJ. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology. 2002;59:245–50.
Oelke M, Bachmann A, Descazeaud A, European Association of Urology, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64:118–40.
Suer E, Gokce I, Yaman O, Anafarta K, Gogus O. Open prostatectomy is still a valid option for large prostates: a high-volume, single-center experience. Urology. 2008;72:90–4.
Serretta V, Morgia G, Fondacaro L, Curto G, Lo bianco A, Pirritano D, et al. Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urol. 2002;60:623–7.
Tan AH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol. 2003;170:1270–4.
Zheng SB, Liu CX, Xu YW. Application of intracavitary retrograde dissection in transurethral vaporization resection of the prostate. Di Yi Jun Yi Da Xue Xue Bao. 2005;25(734–735):738.
Elshal AM, El-Nahas AR, Barakat TS, et al. Transvesical open prostatectomy for benign prostatic hyperplasia in the era of minimally invasive surgery: perioperative outcomes of a contemporary series. Arab J Urol. 2013;11:362–8.
Lucca I, Shariat SF, Hofbauer SL, Klatte T. Outcomes of minimally invasive simple prostatectomy for benign prostatic hyperplasia: a systematic review and meta-analysis. World J Urol. 2015;33(4):563–70.
Pariser JJ, Pearce SM, Patel SG, et al. National trends of simple prostatectomy for benign prostatic hyperplasia with an analysis of risk factors for adverse perioperative outcomes. Urology. 2015;86:721–6. The national use of OP significantly decreased yearly, whereas 5 % of procedures were performed using a minimally invasive approach by 2012. An overall complication rate of 28 % has been reported, with 0.4 % in-hospital mortality. Older age, black race, and overall comorbidity were at higher risk of complications in the multivariate analysis while the use of a minimally invasive approach and concomitant cystolithotomy were associated with a decreased risk.
Li M, Qiu J, Hou Q, et al. Endoscopic enucleation versus open prostatectomy for treating large benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. PLoS One. 2015;10(3), e0121265.
Chen S, Zhu L, Cai J, et al. Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years. Eur Urol. 2014;66:284–91.
Burke N, Whelan JP, Goeree L, et al. Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urology. 2010;75:1015–22.
de Sio M, Autorino R, Quarto G, et al. Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial. Urology. 2006;67:69–72.
Singh H, Desai MR, Shrivastav P, Vani K. Bipolar versus monopolar transurethral resection of prostate: randomized controlled study. J Endourol. 2005;19:333–8.
McVary KT, Roehrborn CG, Avins AL et al (2010) American urological association guideline: management of benign prostatic hyperplasia (BPH). http://www.auanet.org/education/guidelines/benign-prostatic-hyperplasia.cfm. Accessed 23 Feb 2016.
Herrmann TR, Liatsikos EN, Nagele U, et al. EAU guidelines panel on lasers, technologies. Eur Urol. 2012;61:783.
Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol. 2008;53:160–6. At 5 yearS follow-up, there were comparable functional outcomes between HoLEP and OP but HoLEP group has the advantages of shorter hospitalization stay and catheterization times, less blood loss, and lower transfusion rates. Reoperation rates were respectively comparable between both arms while no patient needed redo for recurrent adenoma.
Zhang Y, Du CJ, Xu G, Chen JM, **g X. Transurethral holmium laser enucleation for prostate adenoma greater than 100 g. Zhonghua Nan Ke Xue. 2007;13:1091–93.
Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol. 2006;50:563–8.
Moody JA, Lingeman JE. Holmium laser enucleation for prostate adenoma greater than 100 gm.: comparison to open prostatectomy. J Urol. 2001;165(2):459–62.
Ahyai SA, Chun FK, Lehrich K, et al. Transurethral holmium laser enucleation versus transurethral resection of the prostate and simple open prostatectomy—which procedure is faster? J Urol. 2012;187(5):1608–13.
Alivizatos G, Skolarikos A, Chalikopoulos D, et al. Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80 ml: 12-mo results of a randomized prospective study. Eur Urol. 2008;54:427–37.
Skolarikos A, Papachristou C, Athanasiadis G, et al. Eighteen-month results of a randomized prospective study comparing transurethral photoselective vaporization with transvesical open enucleation for prostatic adenomas greater than 80 cc. J Endourol. 2008;22(10):2333–40.
Vincent MW, Gilling PJ. HoLEP has come of age. World J Urol. 2015;33:487–93.
Humphreys MR, Miller NL, Handa SE, et al. Holmium laser enucleation of the prostate-outcomes independent of prostate size? J Urol. 2008;180:2431–5.
Kuntz RM, Lehrich K, Ahyai S. Does perioperative outcome of transurethral holmium laser enucleation of the prostate depend on prostate size? J Endourol. 2004;18:183–8.
Elkoushy MA, Elshal AM, Elhilali MM. Reoperation after holmium laser enucleation of the prostate for management of benign prostatic hyperplasia: assessment of risk factors with time to event analysis. J Endourol. 2015;29:797–804.
Gilling PJ, Wilson LC, King CJ, et al. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int. 2012;109:408–11.
Jones P, Alzweri L, Rai BP, et al. Holmium laser enucleation versus simple prostatectomy for treating large prostates: results of a systematic review and meta-analysis. Arab J Urol. 2016;14(1):50–8.
Salonia A, Suardi N, Naspro R, et al. Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: an inpatient cost analysis. Urology. 2006;68:302–6.
Robert G, Cornu JN, Fourmarier M, et al. Multicentre prospective evaluation of the learning curve of holmium laser enucleation of the prostate (HoLEP). BJU Int. 2016;117(3):495–9.
Tubaro A, de Nunzio C. The current role of open surgery in BPH. EAU-EBU Update Ser. 2006;4:191–201.
Pfitzenmaier J, Gilfrich C, Pritsch M, et al. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phOPhate laser: midterm-results and comparison with prostates of <80 mL. BJU Int. 2008;102(3):322–7.
Woo HH. Photoselective vaporization of the prostate using the 120-W lithium triborate laser in enlarged prostates (>120 cc). BJU Int. 2011;108:860–3.
Woo H, Reich O, Bachmann A, et al. Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: those in retention, on anticoagulants, and with large prostates (>80 ml). Eur Urol Suppl. 2008;7:378–83.
Ruszat R, Wyler S, Seifert HH, et al. Photoselective vaporization of the prostate: experience with prostate adenomas >80 cm3. Urol A. 2006;45:858–64.
Rajbabu K, Chandrasekara SK, Barber NJ, et al. Photoselective vaporization of the prostate with the potassium titanyl-phOPhate laser in men with prostates of >100 mL. BJU Int. 2007;100:593–8.
Gu X, Vricella GJ, Spaliviero M, Wong C. Does size really matter? The impact of prostate volume on the efficacy and safety of GreenLight HPS laser photoselective vaporization of the prostate. J Endourol. 2012;26:525–30.
Elmansy H, Baazeem A, Kotb A, Badawy H, Riad E, Emran A, et al. Holmium laser enucleation versus photoselective vaporization for prostatic adenoma greater than 60 ml: preliminary results of a prospective, randomized clinical trial. J Urol. 2012;188:216–21.
Horasanli K, Silay MS, Altay B, et al. Photoselective potassium titanyl phOPhate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. Urology. 2008;71:247–51.
Hueber PA, Ben-Zvi T, Liberman D, et al. Mid-term outcomes of initial 250 case experience with GreenLight 120W-HPS photoselective vaporization prostatectomy for benign prostatic hyperplasia: comparison of prostate volumes <60 cc, 60 cc-100 cc and >100 cc. Can J Urol. 2012;19:6450–8.
Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm followup. Eur Urol. 2010;58:349–55.
Altay B, Erkurt B, Kiremit MC, et al. 180-W XPS GreenLight laser vaporization for benign prostate hyperplasia: 12-month safety and efficacy results for glands larger than 80 mL. Lasers Med Sci. 2015;30:317–23.
Ben-Zvi T, Hueber PA, Liberman D, et al. GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia: a prospective comparative analysis after 200 cases in a single-center study. Urology. 2013;81:853–8.
Bachmann A, Muir GH, Collins EJ, et al. 180-W XPS GreenLight laser therapy for benign prostate hyperplasia: early safety, efficacy, and perioperative outcome after 201 procedures. Eur Urol. 2012;61:600–7.
Emara AM, Barber NJ. The continuous evolution of the Greenlight laser; the XPS generator and the MoXy laser fiber, expanding the indications for photoselective vaporization of the prostate. J Endourol. 2014;28:73–8.
Elshal AM, Elkoushy MA, El-Nahas AR, et al. GreenLight™ Laser (XPS) photoselective vapo-enucleation versus holmium laser enucleation of the prostate for the treatment of symptomatic benign prostatic hyperplasia: a randomized controlled study. J Urol. 2015;193(3):927–34. The only RCT which compared vapoenucleation using XPS/180W with HoLEP, which were comparable in improving functional outcomes after 12 months. After 4 months, prostate size reduction was significantly higher in the HoLEP group while electrocautery was necessary for completion of the procedure in 15 % patients undergoing XPS due to large prostate size, which reaches up to 150 ml in some patients.
Sancha FG, Rivera VC, Georgiev G, et al. Common trend: move to enucleation—is there a case for GreenLight enucleation? Development and description of the technique. World J Urol. 2015;33:539–47.
Liu CL, Xue DW, Liu YL, Wang P. Greenlight photoselective vaporization prostatectomy versus thulium laser vaporesection of the prostate for aged high-risk BPH patients with the prostate heavier than 80 g. Zhonghua Nan Ke Xue. 2011;17:431–4.
Sun F, Han B, Cui D, et al. Long‑term results of thulium laser resection of the prostate: a prospective study at multiple centers. World J Urol. 2015;33:503–8. This study reported the longest-term data after ThuVARP, with up to 8 years follow-up. Urethral stricture and bladder neck contracture occurred in 2.6 and 1.6 % of patients, respectively, while reoperation due to recurrence of adenoma was required in 1.2 % patients.
Zhang F, Shao Q, Herrmann TR, Tian Y, Zhang Y. Thulium laser versus holmium laser transurethral enucleation of the prostate: 18 month follow-up data of a single center. Urology. 2012;79:869–74.
Iacono F, Prezioso D, Di Lauro G, et al. Efficacy and safety profile of a novel technique, ThuLEP (Thulium laser enucleation of the prostate) for the treatment of benign prostate hypertrophy. Our experience on 148 patients. BMC Surg. 2012;12 Suppl 1:S21.
Bach T, Netsch C, Pohlmann L, et al. Thulium:YAG vapoenucleation in large volume prostates. J Urol. 2011;186:2323–7.
Gross AJ, Netsch C, Knipper S, et al. Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol. 2014;63:859–67.
Netsch C, Bach T, Herrmann TR, Gross AJ. Update on the current evidence for Tm:YAG vapoenucleation of the prostate 2014. World J Urol. 2015;33(4):517–24.
Kyriazis I, Swiniarski PP, Jutzi S, et al. Transurethral anatomical enucleation of the prostate with Tm:YAG support (ThuLEP): review of the literature on a novel surgical approach in the management of benign prostatic enlargement. World J Urol. 2015;33:525–30.
Yang SS, Hsieh CH, Chiang IN, et al. Prostate volume did not affect voiding function improvements in diode laser enucleation of the prostate. J Urol. 2013;189:993–8.
Lusuardi L, Myatt A, Sieberer M, et al. Safety and efficacy of Eraser laser enucleation of the prostate: preliminary report. J Urol. 2011;186:19671971.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Mohamed A. Elkoushy and Mostafa M. Elhilali each declare no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Benign Prostatic Hyperplasia
Rights and permissions
About this article
Cite this article
Elkoushy, M.A., Elhilali, M.M. Management of Benign Prostatic Hyperplasia Larger than 100 ml: Simple Open Enucleation Versus Transurethral Laser Prostatectomy. Curr Urol Rep 17, 44 (2016). https://doi.org/10.1007/s11934-016-0601-7
Published:
DOI: https://doi.org/10.1007/s11934-016-0601-7